Article Information
vol. 5 no. 2 159-176
PubMed
Print ISSN
Online ISSN
History
- Received March 17, 2020
- Revised April 14, 2020
- Accepted April 15, 2020
- Published online June 30, 2020.
Article Versions
- Previous version (June 18, 2020 - 21:16).
- You are viewing the most recent version of this article.
Copyright & Usage
© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
Author Information
- Liping Liu1,
- Weiqi Chen1,
- Hongyu Zhou1,
- Wanying Duan1,
- Shujuan Li2,
- Xiaochuan Huo1,
- Weihai Xu3,
- Li"an Huang4,
- Huaguang Zheng1,
- Jingyi Liu1,
- Hui Liu2,
- Yufei Wei1,
- Jie Xu1,
- Yongjun Wang1
- Chinese Stroke Association Stroke Council Guideline Writing Committee
- 1 Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
- 2 Department of Neurology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China
- 3 Department of Neurology, Peking Union Medical College Hospital, Beijing, China
- 4 Department of Neurology, Guangzhou Overseas Chinese Hospital, The First Affiliated Hospital of JINAN University, Guangzhou, China
- Correspondence to Dr Yongjun Wang; yongjunwang{at}ncrcnd.org.cn
Article usage
Statistics from Altmetric.com
Vol 5 Issue 2
Table of Contents
- Article
- Abstract
- Introduction
- Section 1: definitions associated with ischaemic cerebrovascular diseases
- Section 2: emergency assessment and diagnosis of patients with ischaemic stroke
- Section 3: reperfusion therapy for AIS
- Section 4: antiplatelet aggregation therapy for acute ischaemic cerebrovascular disease
- Section 5: other treatment in the acute phase
- Section 6: general supportive care and complications management
- Section 7: early evaluation and diagnosis of aetiology and pathogenesis of ischaemic cerebrovascular disease
- Section 8: intervention on aetiology and pathogenesis
- Section 9: management of risk factors and long-term intervention
- Footnotes
- References
- Figures & Data
- eLetters
- Info & Metrics